TG Therapeutics Inc (TGTX.OQ)
TGTX.OQ on NASDAQ Stock Exchange Capital Market
4.76USD
15 Feb 2019
4.76USD
15 Feb 2019
Change (% chg)
$0.06 (+1.28%)
$0.06 (+1.28%)
Prev Close
$4.70
$4.70
Open
$4.71
$4.71
Day's High
$4.81
$4.81
Day's Low
$4.67
$4.67
Volume
309,036
309,036
Avg. Vol
406,645
406,645
52-wk High
$17.30
$17.30
52-wk Low
$3.41
$3.41
About
TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)
Overall
| Beta: | 1.34 |
| Market Cap(Mil.): | $846.68 |
| Shares Outstanding(Mil.): | 68.84 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| TGTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -1.95 | -- | -- |
| ROI: | -129.83 | 8.92 | 14.45 |
| ROE: | -133.51 | 10.08 | 15.96 |
Estimates